Hepatitis C Screening for Employees in Egypt: A Practical Guide for Employers

Short answer: yes, employers in Egypt can offer hepatitis C screening, provided it is voluntary, confidential and linked to confirmation and treatment. Screening starts with an antibody blood test; anyone who tests positive needs a second test, HCV RNA, to confirm whether the infection is still active. The World Health Organization (WHO) states that direct-acting antivirals cure more than 95% of people treated. A test result belongs to the employee, not the employer. This guide is educational and does not replace medical advice.

• WHO (hepatitis C fact sheet, 28 July 2026): an estimated 47 million people live with chronic hepatitis C, and about 239,000 people died of it in 2024, mostly from cirrhosis and liver cancer.
• Most infections cause no symptoms, so chronic infection can go undiagnosed for decades. Testing is the only way to know.
• Testing is two steps: an antibody test first, then an HCV RNA test to confirm active infection. About 30% of people clear the virus on their own and still test antibody-positive.
• WHO: direct-acting antivirals can cure more than 95% of people with hepatitis C, usually over 12 to 24 weeks.
• Egypt: WHO recognised Egypt in October 2023 as the first country to reach the gold tier on the path to eliminating hepatitis C, after testing over 60 million people and treating more than 4 million. Many of your employees may already have been tested, so a workplace programme should be an offer, not an obligation.
• Keep individual results strictly confidential. HR should receive only anonymous, aggregated participation figures.

Why hepatitis C still deserves a place in your employee health programme

Hepatitis C is a bloodborne virus that damages the liver. According to WHO, it is mainly spread through unsafe injections and procedures in health care, unscreened blood transfusions and sharing injection equipment. It is not spread through food, water, breast milk or casual contact, which matters for the workplace: sharing an office, a canteen or a vehicle is not a route of infection.

The difficulty is that most acute infections cause no symptoms, and chronic infection often stays silent until serious liver damage develops. WHO notes it can go undiagnosed for decades. An employee who feels perfectly well may still be infected, and may also be someone who was tested years ago and never received a confirmatory result. That gap is where a confidential, well-run workplace offer can help.

What Egypt's national campaign means for employers

Egypt ran one of the largest hepatitis C programmes in the world. WHO reports that the nationwide "100 million seha" campaign tested over 60 million people and treated more than 4 million, and that new infections fell from 300 per 100,000 people in 2014 to 9 per 100,000 in 2022. WHO recognised Egypt as the first country to reach the gold tier on the path to elimination on 9 October 2023.

Do not read this as "the problem is solved, so no action is needed." Gold tier reflects programme coverage on the path to elimination, and WHO's own target is fewer than 5 new infections per 100,000 people per year. A more useful reading for HR is practical. First, a large share of working-age adults in Egypt has already had a hepatitis C test, so a workplace programme should respect that and never repeat testing unnecessarily. Second, a past positive antibody result is not a diagnosis of current infection, so some employees may still need the confirmatory step. Third, we have not found a current, verified national prevalence figure for adult workers, so we do not quote one and we do not assume your workforce's rate.

Illustrative scenario: a 600-employee factory with three shifts

This is a hypothetical example, not a client case. An HR manager at a manufacturing company in an industrial city wants to add a liver-health component to the annual health day. Instead of mandating tests, the company announces a voluntary session with a short, plain-language note in Arabic: what the test is, that results go only to the employee, and that anyone who already tested negative or was treated need not repeat it. Night-shift staff get a dedicated slot so they are not excluded. The clinical team runs the antibody test, gives each person a private result, and hands anyone with a positive result a written referral for the confirmatory RNA test and a doctor visit. HR receives one page of anonymous numbers: how many were offered, how many took part and how many completed the referral.

How hepatitis C testing works

Step 1: the antibody test (anti-HCV)

A blood sample is tested for antibodies, which show past or current infection. A negative result generally means no infection, although the clinician decides whether a repeat test is needed after a recent possible exposure. A positive result does not by itself mean the person is currently infected.

Step 2: the HCV RNA test

A positive antibody result is followed by a nucleic acid (HCV RNA) test, which detects the virus itself and confirms chronic infection. This step matters because about 30% of people clear the virus without treatment and remain antibody-positive for life. Without it, someone could be told they have an active infection when they do not, or the reverse.

Step 3: assessment and treatment

Anyone with confirmed infection needs a doctor's assessment, which may include liver tests, before treatment. WHO says treatment with direct-acting antivirals usually lasts 12 to 24 weeks depending on whether cirrhosis is present. The treating doctor, not the employer or the screening team, decides the plan.

Who should be offered screening

Offer the test to every interested employee rather than selecting individuals, so nobody is singled out. WHO recommends testing people at increased risk in all settings, including health-care workers, people who have received unscreened transfusions or unsafe injections, and people with signs of liver disease. Which employees fall into those groups, and whether a role carries blood-exposure risk, is a clinical and infection-control decision for your medical provider and the relevant authorities, not for HR.

Voluntary, confidential and non-discriminatory: the ground rules

• Voluntary participation with written, informed consent. Mandatory testing raises legal and ethical issues; confirm any requirement for a specific role with your legal adviser and the competent authorities.
• Results go to the employee and the clinical team only. Medical records stay with the provider, and HR sees anonymous aggregate figures. See our guide on employee health data confidentiality.
• No consequences for declining. Make this explicit in the invitation.
• A clear next step for every positive result: a written referral, a confirmatory test and a doctor visit, so nobody leaves with an unexplained number.
• Do not use the result for hiring or dismissal decisions without legal advice. WHO states the virus is not spread by casual contact, so ordinary office, factory or canteen contact is not a transmission route.

If you also run pre-employment checks, read our guide on the pre-employment medical examination in Egypt first, and take legal advice before adding any infectious-disease test to that process.

How to plan the programme in five steps

1. Agree the clinical protocol with your provider: who performs the tests, which laboratory is used, how results are communicated and how referrals work.
2. Communicate early and plainly in Arabic and English: purpose, voluntary nature, privacy and what happens after a positive result.
3. Run the session privately, with separate time slots for night and site staff, and a quiet room for results.
4. Refer and follow up: give each person with a positive result a written referral and invite them, if they wish, to tell the clinic once they have seen a doctor.
5. Review anonymous indicators once a year: the share of eligible employees who took part, the share of positive results that completed confirmation within an agreed period, and employee feedback. Avoid promising health or cost outcomes in advance.

Fit it into a wider screening day

Hepatitis C testing works best as an optional module within a broader programme rather than a standalone event, which also reduces stigma because nobody can tell which test an employee chose. Pair it with the checks described in our annual employee medical screening guide, and with blood pressure and diabetes screening, both of which we cover in separate guides for Egyptian employers.

When to see a doctor

Anyone who has had a positive hepatitis C result, or who has persistent tiredness, nausea, abdominal pain, dark urine, pale stools or yellowing of the skin or eyes, should see a doctor. Yellowing of the skin or eyes, vomiting blood or sudden confusion needs urgent care; call 123 for an ambulance in Egypt. This is general guidance, and the treating clinician advises individuals.

How Hospitalia can help

Hospitalia is an Egypt-based integrated home healthcare and corporate medical services platform. For employers it offers on-site employee health programmes, doctor consultations and telemedicine, and for individuals, home healthcare services. The scope, laboratory arrangements, staffing, locations and commercial terms of any screening module are confirmed with each client after assessing your sites and workforce.